An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004

Teduglutide 0.05 mg/kg SC injection will be administered once daily into 1 of the 4 quadrants of the abdomen or either thigh or arm.

Teduglutide will be administered using syringe. Syringe is approved for use in Japan by PMDA.

Teduglutide will be administered using needle. Needle is approved for use in Japan by PMDA.

Vial adapter for device is approved for use in Japan by PMDA.